CRISPR-Cas9 is a gene-editing technology that allows for precise modification of DNA sequences within organisms, enabling the addition, deletion, or alteration of specific genetic material.
It addresses the need for efficient and accurate genetic modification techniques that can be used in research, agriculture, and medical treatments.
CRISPR-Cas9 uses an RNA molecule to guide the Cas9 enzyme to a specific location in the genome. Once at the target site, Cas9 makes a double-stranded break in the DNA, which can then be repaired by cellular machinery, leading to precise modifications.
The manufacturing process involves creating RNA guides specific to target sequences, producing Cas9 protein or ribonucleoprotein complexes, and delivering these into cells or organisms.
CRISPR-Cas9 systems are typically built by designing guide RNAs that match the desired DNA sequence. These are then paired with Cas9 proteins and delivered using various methods such as viral vectors, electroporation, or microinjection.
No companies curated for this tile yet.
Curated names only — none are invented. Use the link to find more.
Cost drivers only — no verified dollar figures are shown. Check live sources for prices.
Illustrative — search real, dated examples rather than trusting a generated story.
Live searches — we don't list papers we can't verify.
Live patent searches — filings are never listed from memory.
Verify against primary sources only.
Source: curated technology intelligence stream with tracked references.